magNews

Corporate Industry Technology Medical Updates

Redefining New Boundaries in Delivering Patient Care

magAssist Recognized in 2024 VENTURE50 Awards

MoyoAssist® Extra-VAD® Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China

MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held

Awards

Corporate
magAssist Recognized in 2024 VENTURE50 Awards 2025-01-09
Corporate
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022 2023-03-14
Corporate
magAssist Included in 2022 China Valuable Companies List 2023-01-31
Corporate
magAssist Wins Final of 11th China Innovation & Entrepreneurship Competition 2023-01-13
Corporate
magAssist Included in List of 2022 Potential Unicorn Companies in Jiangsu Province 2022-12-15
Corporate
Dr. Po-Lin Hsu Named on List of Forbes China - 100 Outstanding Overseas Returnees 2022-12-14
Corporate
MoyoAssist®, the winning project for Australian Good Design Awards and Designer Australia Awards 2022. 2022-09-30
Corporate
magAssist was selected as one of the top 50 innovative companies in the 21st century by the world famous innovation list MIC50: Top 50 Innovative Companies 2021-12-23
Corporate
magAssist was awarded the title of "Venture 100 Future Unicorn" 2021-12-17
Corporate
magAssist was named a potential unicorn company in Jiangsu Province 2021-12-02

Tags： Innovation, Application, Extra-VAD, U.S. FDA, Interventional Ventricular Assist Device, Breakthrough Device, VENTURE50, Awards, Healthcare, Difference,